Anders Waage

10PUBLICATIONS
103CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Microbial geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 02, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myeloma.

Karolos Douvlataniotis, Aleksei Titov, Julia Zeun

|Jan 27, 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone.

Tobias S Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen

|Aug 05, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myeloma.

Molly Went, Laura Duran-Lozano, Gisli H Halldorsson

|Nov 29, 2022
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival.

Kristin Roseth Aass, Tonje Marie Vikene Nedal, Siri Anshushaug Bouma

|Jun 01, 2022
Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.

Kristine Misund, Davine Hofste Op Bruinink, Eivind Coward

|May 23, 2022
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.

Mattia D'Agostino, David A Cairns, Juan José Lahuerta

Pageof 2

Frequent Collaborators

4 joint publications

Fredrik Schjesvold

4 joint publications

Tobias Schmidt Slørdahl

3 joint publications

Annette Juul-Vangsted

2 joint publications

Mario Boccadoro